iShares MSCI Europe UCITS ETF EUR (Acc) (LON:SMEA)
Assets | 9.71B |
Expense Ratio | 0.12% |
PE Ratio | 15.29 |
Dividend (ttm) | n/a |
Dividend Yield | n/a |
Ex-Dividend Date | n/a |
Payout Frequency | n/a |
Payout Ratio | n/a |
1-Year Return | +5.17% |
Volume | 33,244 |
Open | 6,968.00 |
Previous Close | 6,947.00 |
Day's Range | 6,947.00 - 6,978.00 |
52-Week Low | 6,026.00 |
52-Week High | 7,262.00 |
Beta | 0.98 |
Holdings | 473 |
Inception Date | Sep 25, 2009 |
About SMEA
iShares MSCI Europe UCITS ETF EUR (Acc) is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. The fund is managed by BlackRock Advisors (UK) Limited. It invests in the public equity markets of developed countries in Europe. The fund seeks to invest in the stocks of companies operating across diversified sectors. It invests in the stocks of mid-cap and large-cap companies. The fund seeks to replicate the performance of the MSCI Europe Index, by employing representative sampling methodology. It was formerly known as iShares III Public Limited Company - iShares MSCI Europe UCITS ETF (Acc). iShares MSCI Europe UCITS ETF EUR (Acc) was formed on September 25, 2009 and is domiciled in Ireland.
Performance
SMEA had a total return of 5.17% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.83%.
Top 10 Holdings
19.23% of assetsName | Symbol | Weight |
---|---|---|
SAP SE | SAP | 2.46% |
Nestlé S.A. | NESN | 2.38% |
ASML Holding N.V. | ASML | 2.23% |
Roche Holding AG | ROG | 1.88% |
Novartis AG | NOVN | 1.86% |
AstraZeneca PLC | AZN | 1.83% |
HSBC Holdings plc | HSBA | 1.72% |
Novo Nordisk A/S | NOVO.B | 1.72% |
Shell plc | SHEL | 1.69% |
Siemens Aktiengesellschaft | SIE | 1.46% |